The global demand for Rapid Covid-19 Antigen Test Kit Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
The rapid coronavirus antigen test kit is a lateral flow immunoassay for the qualitative identification of SARS-COV-2 antigen (nucleocapsid protein) in upper respiratory samples collected using nasal swabs or saliva during the acute phase of infection. The sandwich immunoassay format was used to create this lateral flow assay. Coronavirus N protein binds with colloidal gold-labeled SARS-CoV-2 N protein antibody to produce an antibody-antigen (Ab-Ag) complex when the specimen is placed on the sample pad of a test cassette. SARS-CoV-2 N protein antibody (Rabbit monoclonal antibody) captures the Ab-Ag complex as it migrates to the test line under capillary action. A red color band will appear on the test line, indicating that the specimen is positive for COVID-19 nucleocapsid protein. No colour band will emerge on the test line if the material does not include any coronavirus antigen (N protein) or the antigen level is below the detection limit.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of rapid covid-19 antigen test kit. The growth and trends of rapid covid-19 antigen test kit industry provide a holistic approach to this study.
Market Segmentation
This section of the rapid covid-19 antigen test kit market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
- Chromatographic Immunoassay
- Fluorescent Immunoassay
- Others
By End-User
- Hospitals& Clinics
- Diagnostic Center
- Home Care
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Rapid Covid-19 Antigen Test Kit market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Rapid Covid-19 Antigen Test Kit Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the rapid covid-19 antigen test kit market include Abbott Rapid Diagnostics, Cipla, AMEDA Labordiagnostik GmbH, Becton Dickinson, Beijing Lepu Medical Technology, BIOSYNEX SWISS SA, CerTest Biotech S.L., Hangzhou Clongene Biotech, Healgen Scientific Limited, LumiraDX UK Ltd., nal von Minden GmbH, Quidel Corporation, SD BIOSENSOR, Inc.; Roche, Siemens Healthineers, Xiamen Boson Biotech Co, Zhejiang Orient Gene Biotech Co.,Ltd, and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.